FROM PUBLIC EVENTS · 2026-11-15

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Late clinical · capacity Running its Chungju plant as a gene-therapy production base and widening contract manufacturing.

  • Report on gene-therapy production at the Chungju plant and plans to scale up the bio business. Source

Roles often seen at this stageManufacturing & MSAT · Quality QA & QC · BD & licensing

Companies at the same stage and their people flow →

← Company library
Korea / Company briefSources checked 2026-11-15

Reyon Pharmaceutical

A maker of chemical medicines including injectables, widening into contract development and manufacturing of gene and cell therapies from its Chungju plant.

Chungju plant

Stage unconfirmed

Chungju plant making both chemical and biological medicines, able to produce gene therapies from raw material to finished product.

Official role guide

Reyon Pharmaceutical careers

Current availability unconfirmed

Observed 2026-11-15

Work
Unconfirmed — The official careers page could not be confirmed.
Experience & requirements
Unconfirmed — The official careers page could not be confirmed.

Information from a role guide does not establish a current vacancy.

Sources & coverage 1

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. 최신 설비로 '글로벌 CDMO'…3000억 투자 이연제약 충주공장 ↗이투데이 · Published Date unconfirmed · Sources checked 2026-11-15 · Original unavailable